Anti-EMC1 monoclonal antibody

Pre-made anti-EMC1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EMC1/EMC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0753-Ab-1/ GM-Tg-hg-IP0753-Ab-2Anti-Human EMC1 monoclonal antibodyHuman
GM-Tg-rg-IP0753-Ab-1/ GM-Tg-rg-IP0753-Ab-2Anti-Rat EMC1 monoclonal antibodyRat
GM-Tg-mg-IP0753-Ab-1/ GM-Tg-mg-IP0753-Ab-2Anti-Mouse EMC1 monoclonal antibodyMouse
GM-Tg-cynog-IP0753-Ab-1/ GM-Tg-cynog-IP0753-Ab-2Anti-Cynomolgus/ Rhesus macaque EMC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0753-Ab-1/ GM-Tg-felg-IP0753-Ab-2Anti-Feline EMC1 monoclonal antibodyFeline
GM-Tg-cang-IP0753-Ab-1/ GM-Tg-cang-IP0753-Ab-2Anti-Canine EMC1 monoclonal antibodyCanine
GM-Tg-bovg-IP0753-Ab-1/ GM-Tg-bovg-IP0753-Ab-2Anti-Bovine EMC1 monoclonal antibodyBovine
GM-Tg-equg-IP0753-Ab-1/ GM-Tg-equg-IP0753-Ab-2Anti-Equine EMC1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0753-Ab-1/ GM-Tg-hg-IP0753-Ab-2; GM-Tg-rg-IP0753-Ab-1/ GM-Tg-rg-IP0753-Ab-2;
GM-Tg-mg-IP0753-Ab-1/ GM-Tg-mg-IP0753-Ab-2; GM-Tg-cynog-IP0753-Ab-1/ GM-Tg-cynog-IP0753-Ab-2;
GM-Tg-felg-IP0753-Ab-1/ GM-Tg-felg-IP0753-Ab-2; GM-Tg-cang-IP0753-Ab-1/ GM-Tg-cang-IP0753-Ab-2;
GM-Tg-bovg-IP0753-Ab-1/ GM-Tg-bovg-IP0753-Ab-2; GM-Tg-equg-IP0753-Ab-1/ GM-Tg-equg-IP0753-Ab-2
Products NameAnti-EMC1 monoclonal antibody
Formatmab
Target NameEMC1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EMC1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0753-Ag-1Recombinant multi-species EMC1/ CAVIPMR/ KIAA0090 protein


    Target information

    Target IDGM-IP0753
    Target NameEMC1
    Gene ID23065,230866,362643,702573,612432,101089281,508439,100058734
    Gene Symbol and Synonyms2700016F22Rik,CAVIPMR,EMC1,KIAA0090,RGD1310427
    Uniprot AccessionQ8N766
    Uniprot Entry NameEMC1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000127463
    Target ClassificationN/A

    The target: EMC1, gene name: EMC1, also named as CAVIPMR, KIAA0090. This gene encodes a single-pass type I transmembrane protein, which is a subunit of the endoplasmic reticulum membrane protein complex (EMC). Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.